BACKGROUND: The regulation of gene expression is complex and occurs at many levels, including transcriptional and post-transcriptional, in metazoans. Transcriptional regulation is mainly determined by ...

Sponsored by the California Institute for Regenerative Medicine (CIRM) and hosted by Cedars-Sinai, the 7th Annual Alpha Clinics Network Symposium brings together a wide array of stakeholders, ...

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and ...

Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.

One of the most complex aspects of autism is that it is not one disease—but many. Known more accurately as the autism spectrum disorder, or ASD, experts have long been trying to tease apart the ...

CIRM has one singular mission: Accelerating world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world. A dedication to ...

For Bruce Wisnicki and other Parkinson’s patients, the benefit of most Parkinson’s medications might be summed up with the bromide: “This too shall pass.” Because of the degenerative nature of the ...

Anna Kuehl was in her mid-30’s when she was diagnosed with an early form of macular degeneration (AMD), a condition that results in the loss of central vision and is the leading cause of vision loss ...

Cell-based immunotherapy has become the new-generation cancer medicine, and "off-the-shelf" cell products that can be manufactured at large scale and distributed readily to treat patients are ...

We have come a long way in our ability to help people infected with HIV, the virus that causes AIDS. Antiretroviral therapy, using a combination of HIV medicines, means the disease can now often be ...

Geoffrey Lomax, DrPH, joined the California Institute for Regenerative Medicine in 2005. He is the Associate Director for CIRM’s Patient Access Team. The team manages CIRM’s Clinical Infrastructure ...